Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 3:46 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
View All Commentary (CELG)
Recs
jseymour43 (< 20) Submitted: 8/23/06 9:13 PM : Start Price: $41.87 CELG Score: -62.18
Had its run and will fall out of favor with investors.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK